WO2026058281 - PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS, AND ULCERATIVE COLITIS
National phase entry is expected:
Publication Number
WO/2026/058281
Publication Date
19.03.2026
International Application No.
PCT/IN2025/051474
International Filing Date
10.09.2025
Title **
[English]
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS, AND ULCERATIVE COLITIS
[French]
COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE LA POLYARTHRITE RHUMATOÏDE, DE L'ARTHRITE PSORIASIQUE, DE LA SPONDYLARTHRITE ANKYLOSANTE, DE L'ARTHRITE IDIOPATHIQUE JUVÉNILE POLYARTICULAIRE ET DE LA RECTOCOLITE HÉMORRAGIQUE
Applicants **
KOTHAPUVARI, Pavankumar
Inventors
KOTHAPUVARI, Pavankumar
Priority Data
202441068810
11.09.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2244 | |
| EPO | Filing, Examination, Granting | 10515 | |
| Japan | Filing, Examination, Granting | 2325 | |
| South Korea | Filing, Examination, Granting | 2441 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,265
Contact Us
Abstract[English]
The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of Tofacitinib, Indomethacin and Omega-3 fatty acid or a pharmaceutically acceptable salt thereof. The present invention also relates to use of the said pharmaceutical compositions for the treatment Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Polyarticular Course Juvenile Idiopathic Arthritis, and Ulcerative Colitis.